Carbapenem-resistant Pseudomonas aeruginosa and carbapenem use in Japan: an ecological study

被引:14
|
作者
Terahara, Fumitaka [1 ]
Nishiura, Hiroshi [1 ,2 ]
机构
[1] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan
[2] Japan Sci & Technol Agcy, CREST, Saitama, Japan
基金
日本科学技术振兴机构; 日本学术振兴会;
关键词
Antibiotic resistance; Pseudomonas aeruginosa; carbapenem; drug prescription; epidemiology; antimicrobial stewardship; RISK-FACTORS; ANTIMICROBIAL RESISTANCE; CONSUMPTION; TRENDS; IMPACT;
D O I
10.1177/0300060519864181
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective This study focused on carbapenem resistance in Pseudomonas aeruginosa and examined potential ecological correlations with carbapenem use in Japan. Methods The proportion of carbapenem-resistant P. aeruginosa isolates from 2015 and 2016 by prefecture was obtained from the Japan Nosocomial Infections Surveillance system. Data on carbapenem use was obtained from the National Database of Health Insurance Claims. The correlation between the proportion of carbapenem-resistant isolates and carbapenem consumption was assessed in a cross-sectional manner. The study also collected information on other variables including the numbers of physicians, nurses and medical facilities per 100 000 individuals by prefecture. Results Both the proportion of carbapenem-resistant P. aeruginosa isolates and levels of carbapenem use were higher in western Japan. Using a multivariate model, only carbapenem use remained significantly associated with the proportion of carbapenem-resistant isolates. Conclusions Carbapenem use and the proportion of carbapenem-resistant P. aeruginosa isolates were positively correlated. By longitudinal data collection, this approach offers an avenue to establish causal links as the frequency of carbapenem-resistant P. aeruginosa isolates starts to change in the future.
引用
收藏
页码:4711 / 4722
页数:12
相关论文
共 50 条
  • [41] Nosocomial Transmission of Carbapenem-Resistant Pseudomonas aeruginosa among Burn Patients
    Maillet, Mylene
    Pelloux, Isabelle
    Forli, Alexandra
    Vancoetsem, Karen
    Sing, Jacqueline Shum Cheong
    Marfaing, Sylvie
    Ducki, Sebastien
    Batailler, Pierre
    Mallaret, Marie-Reine
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (05): : 597 - 599
  • [42] Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa, Zhejiang Province, China
    Hu, Yan-Yan
    Cao, Jun-Min
    Yang, Qing
    Chen, Shi
    Lv, Huo-Yang
    Zhou, Hong-Wei
    Wu, Zuowei
    Zhang, Rong
    EMERGING INFECTIOUS DISEASES, 2019, 25 (10) : 1861 - 1867
  • [43] Bulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms
    Skalweit, Marion J.
    Li, Mei
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 3013 - 3020
  • [44] Risk factors and outcome associated with coinfection with carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumanii: a descriptive analysis
    Sophonsri, Anthony
    Kelsom, Corey
    Lou, Mimi
    Nieberg, Paul
    Wong-Beringer, Annie
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [45] Classification of the metallo 13-lactamase subtype produced by the carbapenem-resistant Pseudomonas aeruginosa isolates in Japan
    Nakayama, Ryo
    Inoue-Tsuda, Megumi
    Matsui, Hidehito
    Ito, Tamaki
    Hanaki, Hideaki
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (02) : 170 - 175
  • [46] Susceptibility of ceftolozane/tazobactam against multidrug-resistant and carbapenem-resistant Pseudomonas aeruginosa
    Kakehi, Ayaka
    Hagiya, Hideharu
    Iio, Koji
    Fujimori, Takumi
    Okura, Mami
    Minabe, Hiroshi
    Yokoyama, Yukika
    Otsuka, Fumio
    Higashikage, Akihito
    NEW MICROBIOLOGICA, 2023, 46 (02): : 213 - 215
  • [47] Treatment Outcomes for Carbapenem-Resistant and Cephalosporin-Susceptible Pseudomonas aeruginosa Pneumonia
    Ng, Tsz Hin
    Zhao, Jing J.
    Gumbleton, Ryan
    Olson, Shannon
    Smith, Stephanie
    Scipione, Marco R.
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (06) : 581 - 588
  • [48] Aminoglycoside-modifying Enzymes in Carbapenem-resistant Pseudomonas aeruginosa Clinical Isolates
    Tanriverdi Cayci, Yeliz
    Cirit, Osman Sezer
    Biyik, Ilknur
    Cinar, Canberk
    Gur Vural, Demet
    Bilgin, Kemal
    Birinci, Asuman
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2022, 11
  • [49] Carbapenem-resistant Pseudomonas aeruginosa - clonal spread in Southern Brazil and in the State of Goias
    Scheffer, Mara Cristina
    Gales, Ana Cristina
    Barth, Afonso Luis
    do Carmo Filho, Jose Rodrigues
    Dalla-Costa, Libera Maria
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2010, 14 (05): : 508 - 509
  • [50] In vivo dynamics of carbapenem-resistant Pseudomonas aeruginosa selection after suboptimal dosing
    Tam, Vincent H.
    Ledesma, Kimberly R.
    Schilling, Amy N.
    Lim, Tze-Peng
    Yuan, Zhe
    Ghose, Romi
    Lewis, Russell E.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2009, 64 (04) : 427 - 433